Company Filing History:
Years Active: 2021-2022
Title: Akinori Sugiyama: Innovator in Transdermal Drug Delivery
Introduction
Akinori Sugiyama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. With a total of 2 patents to his name, Sugiyama's work focuses on enhancing drug permeability and stability.
Latest Patents
Sugiyama's latest patents include a transdermal absorption preparation that boasts superior drug skin permeability. This innovative preparation allows for the uniform dispersion of the drug within the formulation, maintaining a consistent state. The transdermal absorption preparation features a plaster layer that contains a drug, a polymer, and a pH adjuster. Notably, the polymer used has a specific glass transition temperature ranging from 30°C to 200°C, and the plaster layer's surface maintains a pH between 6.7 and 10.0.
Another significant patent involves the production method of a pregabalin-containing composition. This method effectively suppresses the crystallization of pregabalin, resulting in a stable composition. The production process includes several steps designed to ensure the quality and efficacy of the pregabalin-containing composition.
Career Highlights
Akinori Sugiyama is associated with Nitto Denko Corporation, a company known for its innovative solutions in various industries, including healthcare. His work at the company has allowed him to focus on advancing drug delivery technologies, contributing to improved patient outcomes.
Collaborations
Sugiyama has collaborated with notable colleagues, including Chie Matsumoto and Tomohito Takita. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Akinori Sugiyama's contributions to the field of pharmaceuticals, particularly in transdermal drug delivery, highlight his role as a significant inventor. His patents reflect a commitment to improving drug formulations and enhancing patient care.